{"schema_version":"secwatch.filing_event.v1","accession":"0001022079-23-000006","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2023-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.537890+00:00","generated_at":"2026-06-20T01:41:06.763526+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Quest Diagnostics Q4 revenue down 15% to $2.33B; base business up 6.3%; raises dividend 7.6%","bullets":["Q4 reported net revenues $2.33B (-15% YoY); base business revs $2.15B (+6.3%); COVID revs $184M (-74.6%).","Q4 reported diluted EPS $0.87 (down 72.1%); adjusted diluted EPS $1.98 (down 40.5%).","Full year 2022 net revenues $9.88B (-8.4%); base business revs $8.43B (+5.1%); COVID revs $1.45B (-47.5%).","FY2023 guidance: net revs $8.83-9.03B; base business up 2.6-3.8%; adjusted EPS $8.40-$9.00.","Board increased quarterly dividend 7.6% to $0.71 (payable Apr 24) and authorized additional $1B share repurchase."],"urls":{"canonical":"https://secwatch.observer/filing/0001022079-23-000006","json":"https://secwatch.observer/filing/0001022079-23-000006.json","markdown":"https://secwatch.observer/filing/0001022079-23-000006.md","text":"https://secwatch.observer/filing/0001022079-23-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000102207923000006/0001022079-23-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000102207923000006/dgx-20230202.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T01:41:06.763526+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c43a998738407dbe0dbc1bb8a8275f2b003e374","claim":"QUEST DIAGNOSTICS INC reported Full year 2023 results: revenue $8.83 billion $9.03 billion, EPS $7.61 $8.21. Guidance initiated.","evidence_excerpt":"We estimate full year 2023 guidance as follows: Low High Net revenues $8.83 billion $9.03 billion Net revenues decrease (10.7)% (8.6)% Base business revenues (a) $8.65 billion $8.75 billion Base business revenues increase 2.6% 3.8% COVID-19 testing revenues $175 million $275 million COVID-19 testing revenues decrease (88.0)% (81.1)% Reported diluted EPS $7.61 $8.21 Adjusted diluted EPS $8.40 $9.00 Cash provided by operations At least $1.3 billion Capital expenditures Approximately $400 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207923000006/0001022079-23-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full year 2023"},{"label":"Revenue","value":"$8.83 billion $9.03 billion"},{"label":"EPS","value":"$7.61 $8.21"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"6478788dd2714679b1ef670bcdb59674ca15d746","claim":"QUEST DIAGNOSTICS INC reported Three Months Ended December 31, 2022 results: revenue $2.33 billion, net income $101 million, EPS $0.87.","evidence_excerpt":"Fourth quarter revenues of $2.33 billion, down 15.0% from 2021 • Fourth quarter reported diluted earnings per share (\"EPS\") of $0.87, down 72.1% from 2021; and adjusted diluted EPS of $1.98, down 40.5% from 2021","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207923000006/0001022079-23-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Three Months Ended December 31, 2022"},{"label":"Revenue","value":"$2.33 billion"},{"label":"Net income","value":"$101 million"},{"label":"EPS","value":"$0.87"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"a6638faf1244d228d20a247a08d5aa0cc2a64ad1","claim":"QUEST DIAGNOSTICS INC reported Full year ended December 31, 2022 results: revenue $9.88 billion, net income $946 million, EPS $7.97.","evidence_excerpt":"Full year revenues of $9.88 billion, down 8.4% from 2021 • Full year reported diluted EPS of $7.97, down 48.7% from 2021; and adjusted diluted EPS of $9.95, down 30.1% from 2021","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207923000006/0001022079-23-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full year ended December 31, 2022"},{"label":"Revenue","value":"$9.88 billion"},{"label":"Net income","value":"$946 million"},{"label":"EPS","value":"$7.97"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}